Niacin is still beneficial. Implications from an updated meta-regression analysis

Acta Cardiol. 2016 Aug;71(4):463-72. doi: 10.2143/AC.71.4.3159701.
No abstract available

Publication types

  • Meta-Analysis

MeSH terms

  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / metabolism
  • Cardiovascular Diseases* / prevention & control
  • Cholesterol, HDL / blood*
  • Cholesterol, LDL / blood*
  • Clinical Trials as Topic
  • Humans
  • Hypolipidemic Agents / pharmacology
  • Niacin / pharmacology*
  • Risk Factors
  • Treatment Outcome
  • Triglycerides / blood*

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Hypolipidemic Agents
  • Triglycerides
  • Niacin